Rephonic
Artwork for The Uromigos

The Uromigos

The Uromigos
Prostate Cancer
Bladder Cancer
Clinical Trials
Kidney Cancer
Pembrolizumab
Muscle-Invasive Bladder Cancer
Immunotherapy
Renal Cell Carcinoma
Belzutifan
Overall Survival
Urothelial Cancer
Enzalutamide
Adjuvant Therapy
Abiraterone
PARP Inhibitors
Cabozantinib
Biomarkers
Non-Muscle Invasive Bladder Cancer
Renal Cancer
Chemotherapy

Broadcasting the latest developments in GU cancer Hosted by Brian Rini and Tom Powles Brian Rini MD is an Ingram Professor of Medicine (Hematology/Oncology), Vanderbilt-Ingram Cancer Center Tom Powles is the Director of Barts Cancer Centre, St Bartholomew's Hospital and Professor of Genitourinary Oncology, Queen Mary University of London

PublishesDailyEpisodes506Founded7 years ago
Number of ListenersCategories
MedicineHealth & Fitness

Listen to this Podcast

Artwork for The Uromigos

Latest Episodes

The final session of this year’s meeting discusses exciting T cell engager and CAR-T data from ESMO 2026. Are these approaches finally ready for prime time in mRCC?

Doublet therapy has produced positive results in the adjuvant and refractory RCC settings. Are they the standard of care and what is the role of monotherapy for individual patients?

Recent attempts to build on the IO-doublet backbone in front-line clear cell RCC therapy have failed including LITESPARK-012. The panel discusses issues that have impacted these trials and where we go from here.

Several third agents added to the ADT/ARPI backbone in mHSPC have emerged in the last year including radioligands and PARP inhibitors. Navigating application to individual patients is discussed by our expert panel.

Key Facts

Accepts Guests
Contact Information
Podcast Host
Number of Listeners
Find out how many people listen to this podcast per episode and each month.

Similar Podcasts

People also subscribe to these shows.

GU Cast | Urology Podcast
GU Cast | Urology PodcastProfessor Declan Murphy & Dr Renu Eapen
Two Onc Docs
Two Onc DocsSam and Karine
Plenary Session
Plenary SessionVinay Prasad

Recent Guests

Hans Hammers
Medical oncologist at UT Southwestern
UT Southwestern
Episode: Episode 540 - Uromigos Live 2026 – T Cell Engagers in RCC: Have We Finally Turned a Corner?
Monty Powell
Medical oncologist at City of Hope
City of Hope
Episode: Episode 540 - Uromigos Live 2026 – T Cell Engagers in RCC: Have We Finally Turned a Corner?
James Larkin
Medical oncologist at the Royal Marsden in London
Royal Marsden
Episode: Episode 540 - Uromigos Live 2026 – T Cell Engagers in RCC: Have We Finally Turned a Corner?
David McDermott
Medical oncologist in Boston
Episode: Episode 540 - Uromigos Live 2026 – T Cell Engagers in RCC: Have We Finally Turned a Corner?
Monty Palma
Medical oncologist at City of Hope
City of Hope
Episode: Episode 538 - Uromigos Live 2026 – Triplet Therapy in mRCC: What Went Wrong?
Laurence Albiges
Medical oncologist at Gustave Roussy
Gustave Roussy
Episode: Episode 538 - Uromigos Live 2026 – Triplet Therapy in mRCC: What Went Wrong?
Hans Amers
Medical oncologist focused on kidney cancer
UT Southwestern
Episode: Episode 538 - Uromigos Live 2026 – Triplet Therapy in mRCC: What Went Wrong?
Neeraj Agarwal
Genitourinary medical oncologist at Dana-Farber Cancer Institute specializing in prostate cancer
Dana-Farber Cancer Institute
Episode: Episode 537 - Uromigos Live 2026 – Sequencing of Therapy Across the Continuum of Advanced Prostate Cancer
Tanya Dorff
Genitourinary medical oncologist at City of Hope
City of Hope
Episode: Episode 537 - Uromigos Live 2026 – Sequencing of Therapy Across the Continuum of Advanced Prostate Cancer

Hosts

Tom Powles
Co-host of The Uromigos; Professor of Genitourinary Oncology; Director of Barts Cancer Centre; affiliated with Queen Mary University of London and Barts Cancer Centre
Brian Rini
Host of The Uromigos; Ingram Professor of Medicine (Hematology/Oncology); affiliated with Vanderbilt-Ingram Cancer Center

Reviews

4.8 out of 5 stars from 183 ratings
  • Amazing information!

    I am no medical doctor but a PhD researcher in big pharma. Love the details and makes you keep updated with the latest medical findings. Will help if doctors can elaborate when they talk about treatment if it’s 1L or 2L etc.

    Apple Podcasts
    5
    gERDorNerd
    United Statesa month ago
  • Excellent resource for patients anddocs

    The Uromigos keep patients and doctors informed with the very latest studies and research in urogenital cancer. I appreciate their hopeful, upbeat and revealing interviews with cutting edge researchers.

    Apple Podcasts
    5
    Tea Green
    United Statesa year ago
  • Informative podcast

    This podcast is a one-stop shop for all things GU oncology. The information is balanced, up to date and relevant for anyone in this field

    Apple Podcasts
    5
    F93111111
    United Kingdom2 years ago
  • Great for staying up on GU oncology

    Drs. Powles and Rini are some of the most eminent current leaders in GU oncology. In this podcast, they discuss recent key studies in the field and really break down the key questions clinicians and patients want to know — are they clinically significant, will they change practice, and what are the next steps? Also, there are a lot of cheesy jokes which this humble listener somehow enjoys.

    Apple Podcasts
    5
    Attentive listener 12345
    United States3 years ago
  • Topical and interesting

    Great discussion of topical issues within the urology space from a engaging, experienced and knowledgeable group of oncologists.

    Apple Podcasts
    5
    Antman1805
    Australia3 years ago

Listeners Say

Key themes from listener reviews, highlighting what works and what could be improved about the show.

Engaging hosts balance data critique with approachable humor, making dense topics accessible.
Guests are subject-matter experts who translate complex trials for clinicians and patients.
Shows high-quality, up-to-date GU oncology data explained clearly.
Great resource for trainees and practicing oncologists alike.

Chart Rankings

How this podcast ranks in the Apple Podcasts, Spotify and YouTube charts.

Talking Points

Recent interactions between the hosts and their guests.

Episode 532 - Uromigos Live 2026 – MIBC: How Does VOLGA Change the Landscape?
Q: Are you comfortable giving less than a year of immune therapy to anyone in this setting, providing they're tolerating it okay?
Panelists generally favor continuing immunotherapy when it is tolerated, but they acknowledge uncertainty. Some would consider stopping early for selected older patients with T2N0 disease and a pathological complete response.
Episode 532 - Uromigos Live 2026 – MIBC: How Does VOLGA Change the Landscape?
Q: What was your big take home message from Volga?
Jonathan Rosenberg says VOLGA represents a minimalist postoperative approach, while other trials tested more intensive therapy. He argues future studies should tailor treatment to postoperative risk rather than apply the same regimen to everyone.
Episode 533 - Uromigos Live 2026 – MIBC: Does ctDNA and/or utDNA Have a Role?
Q: Where are we with pathological complete response and ctDNA? Is one better than the other, or do they both have a role?
Panelists say the measures provide complementary information: ctDNA positivity is strongly concerning, while pathological response and emerging urinary tumor DNA results can contribute additional information to treatment and trial decisions.
Episode 533 - Uromigos Live 2026 – MIBC: Does ctDNA and/or utDNA Have a Role?
Q: Does ctDNA and does the MTM level in terms of its clearance and change affect the way you think?
A panelist says ctDNA changes may be useful in the preoperative setting, but that the available evidence does not show that small changes or clearance in the postoperative setting reliably predict good outcomes.
Episode 535 - Uromigos Live 2026 – MIBC: The Evolution of Antibody Drug Conjugates (ADCs) in Bladder Cancer
Q: If a patient who achieved a complete response becomes circulating tumor DNA positive after stopping treatment, what would you do?
The panel debated restarting EV plus pembrolizumab immediately versus increasing surveillance and waiting for radiographic relapse. Some favored early retreatment, while others highlighted the absence of trial evidence and the need for studies.

Audience Metrics

Listeners, social reach, demographics and more for this podcast.

Listeners per Episode
Gender Skew
Location
Interests
Professions
Age Range
Household Income
Social Media Reach

Frequently Asked Questions About The Uromigos

What is The Uromigos about and what kind of topics does it cover?

The show consistently provides expert-led analysis of GU cancers, with a strong focus on trial design, biomarker-driven strategies, and real-world applicability of high-stakes data. Conversations span prostate, bladder, kidney cancers and emerging modalities like targeted ADCs, radioligand therapy, and AI-enabled evidence. Hosts guide rigorous debates about trial endpoints, regulatory implications, and how new data could shift practice, while maintaining a personable, accessible tone that blends humor with clinical insight. Noteworthy is the blend of frontline clinicians, translational scientists, regulatory voices, and senior researchers, which gives listeners a practical sense of what data means for patient care and decision-making in rea... more

Where can I find podcast stats for The Uromigos?

Rephonic provides a wide range of podcast stats for The Uromigos. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to The Uromigos and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.

How many listeners does The Uromigos get?

Rephonic provides a full set of podcast information for four million podcasts, including the number of listeners. View further listenership figures for The Uromigos, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.

What are the audience demographics for The Uromigos?

Rephonic provides comprehensive predictive audience data for The Uromigos, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.

How many subscribers and views does The Uromigos have?

To see how many followers or subscribers The Uromigos has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.

Which podcasts are similar to The Uromigos?

These podcasts share a similar audience with The Uromigos:

1. GU Cast | Urology Podcast
2. Two Onc Docs
3. Prostate Cancer Update
4. Plenary Session
5. Oncology Brothers: Practice-Changing Cancer Discussions

How many episodes of The Uromigos are there?

The Uromigos launched 7 years ago and published 506 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.

How do I contact The Uromigos?

Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.

Where can I see ratings and reviews for The Uromigos?

Rephonic pulls ratings and reviews for The Uromigos from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.

View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.

How do I access podcast episode transcripts for The Uromigos?

Rephonic provides full transcripts for episodes of The Uromigos. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.

What guests have appeared on The Uromigos?

Recent guests on The Uromigos include:

1. Hans Hammers
2. Monty Powell
3. James Larkin
4. David McDermott
5. Monty Palma
6. Laurence Albiges
7. Hans Amers
8. Neeraj Agarwal

To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.

Find and pitch the right podcasts

We help savvy brands, marketers and PR professionals to find the right podcasts for any topic or niche. Get the data and contacts you need to pitch podcasts at scale and turn listeners into customers.
Try it free for 7 days